title: Pulmonary Embolism.
abstract: Pulmonary embolism covers a wide spectrum of presentation from an asymptomatic individual to a life-threatening medical emergency. It is of paramount importance to appropriately risk stratify patients with pulmonary embolism, particularly with those who present without hypotension. Right ventricular dysfunction can evolve after a patient has received a diagnosis of pulmonary embolism, necessitating aggressive measures rather than simple anticoagulation. In this review, we discuss definition, risk stratification, pathogenesis, diagnostic approach, and management, with particular focus on massive pulmonary embolism.
authors.affiliation: Division of Pulmonary and Critical Care, Allegheny General Hospital, Pittsburgh, Pennsylvania.
authors.forename: Parth
authors.initials: P
authors.lastname: Rali
authors.forename: Viral
authors.initials: V
authors.lastname: Gandhi
authors.forename: Khalid
authors.initials: K
authors.lastname: Malik
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D017128:Embolectomy; D006801:Humans; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000628:therapy; D018570:Risk Assessment; D015912:Thrombolytic Therapy; D018497:Ventricular Dysfunction, Right / Q000175:diagnosis
chemical_list: D000925:Anticoagulants; D015415:Biomarkers